Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02433522
Recruitment Status : Completed
First Posted : May 5, 2015
Last Update Posted : April 19, 2021
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris